HRTX

$HRTX chatter on StockTwits

• 
  Don Genaro@Stock76549m

  $HRTX If we are talking about a buyout, I don't think there is any need to rush it if the BOD believes that the next few quarters could be more successful. There is currently hope that the pre syringed ZYN could be a game changer. However, CINVANTI should be sold at the earliest opportunity if the BOD sees a risk in the patent dispute and if a favorable situation arises for the sale.

  View on StockTwits ↗
• 
  tacto@Tacto5h

  $HRTX Daily short volume was a whopping 69% No surprise there. Looking at availability in the shorting pool, among other stats, you can see that the vast bulk of overall activity is bogus, primarily generated by way of circular ridiculousness, with no genuine shares involved, since all real shares are tightly held by institutions . . .

  View on StockTwits ↗
• 
  tacto@Tacto7h

  $HRTX 😆 Aside from being able to so easily smell a FUD puppet a mile away, the foremost glaring indicator is that they will never provide any solid information in the form of facts or statistics to support their constant theme that nobody should come near this stock, primarily because there is no real basis to support their blather, and even if there was, they'd be sacked by their crime syndicate employer for straying from their mission, which is strictly to spread fertilizer on forums such as this. The funniest part is, unlike with a lot of stocks that the crime syndicate operators go after which are easy targets because they have large retail ownership, HRTX has only ~1% retail ownership, so who's the f'n dimwit now, as if there's any benefit in attempting to wrest such a minuscule amount of the overall float from retail holders to try and cover or settle their short positions that total many tens of millions. That's simply laughable! 😆

  View on StockTwits ↗
• 
  InvestmentEagle@investmenteagleBearish8h

  $HRTX folks there is not going to be any pop on this stock tomorrow. ignore these fake influencers. One can still make money on this, but now is not that time.

  View on StockTwits ↗
• 
  K3vl4r L4bs@k3vl4r10h

  $HRTX is on my radar for tomorrow’s push. The model shows 1h-1wk bullish probabilities at 100%. Tracking it as a potential end-of-day play, no hard sell, just a low-key watch. #stocks #StockMarket

  View on StockTwits ↗
• 
  tacto@Tacto10h

  $HRTX UBS increased their stake by >31% in Q2, per their filing today, giving them a total of 2,997,073 shares of Heron Therapeutics What do the bankers know, that the FUD puppets pretend not to know... . . .

  View on StockTwits ↗
• 
  tacto@Tacto11h

  $HRTX Short stains' stop-losses are congregated around $0.43 Chandelier Exit (Short, 3 ATRs) = $0.43 Upper Bollinger Band = $0.58 Chandelier Exit (Long, 3 ATRs) = $0.41 Lower Bollinger Band = $0.33 RSI (14) = 28.06 Retail only owns ~1% of HRTX, while institutions own 92% . .

  View on StockTwits ↗
• 
  tacto@Tacto11h

  $HRTX Stochastic Buy Signal coming tomorrow. In the lower part of the picture, you can see that %K (blue) has turned and is poised to cross above %D (red) in oversold territory (<20%) . .

  View on StockTwits ↗
• 
  Mike Limbers@Webfoot11h

  $HRTX Well here we are waiting and waiting and waiting for management to turn this around, which doesn’t look promising. Hat to say that a buyout is looking like our best chance of not losing all the money we all have invested. What's surprising is the big guys haven't dumped their shares. They know more than we as retail investor will ever know. Sure would love to be a fly on the wall to see what discussions the institutions have about Heron. .

  View on StockTwits ↗
• 
  bill@chance11114h

  $HRTX There will be no significant upward movement until there is a buyout, if that even happens. Please don't listen to the nonsense being posted by @tacto. Everything he has predicted has not come true and his prediction of a big move this week is not going to happen. Anyone who listens to the gibberish that he posts every night, should really wake up and smell the coffee. The only thing that could cause a move upward other than a buyout, is a positive court ruling on civanti. That is very unlikely to happen according to the "experts". So here we are going nowhere waiting for the next earnings report that will probably sink the stock price lower. Moving sideways as the rest of the market moves up. We are not only losing money on heron, but also on the money we could be making if our money was in a worth while stock. Can't even sell heron at these depressed prices.

  View on StockTwits ↗
• 
  Patience@keypatienceBullish14h

  $HRTX

  View on StockTwits ↗
• 
  High Fade@Highfade15h

  $HRTX seems like the patent decision is a couple months out so may not be a damn thing happening with this POS in the short term other then the bots and shorts playing games….obviously CC gives no ducks and is taking his marching orders from somewhere else….someone on the board threw out the poison pill scenario but all this drama starting to sound like same noise…. GLTA

  View on StockTwits ↗
• 
  fsd@Simplejackinvestor15h

  $HRTX fuck this

  View on StockTwits ↗
• 
  Bull's Theory@bullishonHRTXBullish17h

  $HRTX

  View on StockTwits ↗
• 
  Ricky Bobby@SpaceForceOne18h

  $HRTX Expecting Pacira to announce any day they have bought rights to Zyn and have shelved it. Case closed. Lmao

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.